Virginia · Nonprofit
RX DRUG ACCESS PARTNERSHIP
RX DRUG ACCESS PARTNERSHIP (Virginia) receives grants from 30 organizations whose IRS filings report $1,570,658 to it, the largest being POTOMAC HEALTH FOUNDATION ($365,000). 20 of them have funded it in more than one year.
- Revenue FY2025
- $804k
- Funders on record
- 30
- Grants received
- $1.6M
- Net assets
- $1.5M
What Rx Drug Access Partnership does
Mission
Rx partnership is a public/private partnership which exists to increase access to essential medication for virginia's vulnerable populations and serve as a resource to the organizations that support these populations.
As stated on its FY2025 Form 990.
Program
Rx partnership coordinates free medication from pharmaceutical companies and arranges for distribution directly to nonprofit, licensed pharmacies which it credentials and monitors. Rx partnerhip also supports medication delivery to clinics without a licensed pharmacy. During the year ended june 30, 2025, rx partnership provided its 31 clinic partners with access to free medication to support over 11,270 uninsured virginians. Brand and generic medications obtained through the rx partnership program filled over 62,423 prescriptions with a value of more than 23.1 million. These medications treat chronic illnesses such as asthma, diabetes, hypertension, and depression. For every dollar donated to rx partnership, 28 in prescrption value was delivered to clinic patients.
$643,787 spent$92,357 earned by the program100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $643,787.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2019 to 2020, from $909k to $1.1M (+19%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2021 8% · 2023 21% · 2024 19% · 2025 25%. Grants only. Government contracts and fees sit inside program revenue.
82% of RX DRUG ACCESS PARTNERSHIP’s revenue is contributions — about as donation-reliant as the typical peer (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 9 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Board chair
Shawn Nelson
Chair
As listed on its FY2025 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 6 funders to 16 funders, grant income rose $102k → $237k.
6 of 30 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 6% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $936k from 10 payers (the payer shares this organization's board, largest Williamsburg Community Health Foundation). These are real filings, and they are not money RX DRUG ACCESS PARTNERSHIP raised.
From the IRS filings of RX DRUG ACCESS PARTNERSHIP’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
RX DRUG ACCESS PARTNERSHIP has a broad base — no single funder exceeds 23% of grant income, and it takes 4 funders to reach half.
the vertical line marks half of all grant income — 4 funders to its left
37% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund RX DRUG ACCESS PARTNERSHIP.
Largest funder’s share by year: 2017 42% · 2018 29% · 2019 48% · 2020 18% · 2021 23% · 2022 19% · 2023 17% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
69% of RX DRUG ACCESS PARTNERSHIP's funders are still giving 3 years after their first grant; 67% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
91% of RX DRUG ACCESS PARTNERSHIP's grant income comes from Virginia funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $100k arriving through sponsors registered in 3 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
RX DRUG ACCESS PARTNERSHIP's funding base is broadening — from 6 funders to 16 as grant income climbed.
this organization peer median middle 50% of peers· 7,883 health nonprofits $100k–$1M, FY2025
Organizations like RX DRUG ACCESS PARTNERSHIP
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Virginia
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
80% of spending goes to programs.
Governance
Public support
77%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Screen this organization
A dated, signed PDF of the compliance screen for RX DRUG ACCESS PARTNERSHIP: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds RX DRUG ACCESS PARTNERSHIP?
- RX DRUG ACCESS PARTNERSHIP (Virginia) receives grants from 30 organizations whose IRS filings report $1,570,658 to it, the largest being POTOMAC HEALTH FOUNDATION ($365,000). 20 of them have funded it in more than one year.
- How many funders does RX DRUG ACCESS PARTNERSHIP have?
- IRS filings report 30 organizations giving $1,570,658 in grants to RX DRUG ACCESS PARTNERSHIP, 20 of which have funded it in more than one year.
- Who is the largest funder of RX DRUG ACCESS PARTNERSHIP?
- POTOMAC HEALTH FOUNDATION is the largest funder on record, with $365,000 in grants. The full list of funders is on this page.
- How can an organization like RX DRUG ACCESS PARTNERSHIP find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Virginia. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Rx Drug Access Partnership →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 30 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing